Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.
Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/801c70ba21a348528b99e6c36c4f4533 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:801c70ba21a348528b99e6c36c4f4533 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:801c70ba21a348528b99e6c36c4f45332021-11-18T08:53:33ZNovel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing.1932-620310.1371/journal.pone.0076623https://doaj.org/article/801c70ba21a348528b99e6c36c4f45332013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24086756/?tool=EBIhttps://doaj.org/toc/1932-6203Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role.Sophie EisenreichKhalil Abou-El-ArdatKarol SzafranskiJaime A Campos ValenzuelaAndreas RumpJanice M NigroRolf BjerkvigEva-Maria GerlachKarl HackmannEvelin SchröckDietmar KrexLars KaderaliGabriele SchackertMatthias PlatzerBarbara KlinkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e76623 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sophie Eisenreich Khalil Abou-El-Ardat Karol Szafranski Jaime A Campos Valenzuela Andreas Rump Janice M Nigro Rolf Bjerkvig Eva-Maria Gerlach Karl Hackmann Evelin Schröck Dietmar Krex Lars Kaderali Gabriele Schackert Matthias Platzer Barbara Klink Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
description |
Oligodendroglial tumors form a distinct subgroup of gliomas, characterized by a better response to treatment and prolonged overall survival. Most oligodendrogliomas and also some oligoastrocytomas are characterized by a unique and typical unbalanced translocation, der(1,19), resulting in a 1p/19q co-deletion. Candidate tumor suppressor genes targeted by these losses, CIC on 19q13.2 and FUBP1 on 1p31.1, were only recently discovered. We analyzed 17 oligodendrogliomas and oligoastrocytomas by applying a comprehensive approach consisting of RNA expression analysis, DNA sequencing of CIC, FUBP1, IDH1/2, and array CGH. We confirmed three different genetic subtypes in our samples: i) the "oligodendroglial" subtype with 1p/19q co-deletion in twelve out of 17 tumors; ii) the "astrocytic" subtype in three tumors; iii) the "other" subtype in two tumors. All twelve tumors with the 1p/19q co-deletion carried the most common IDH1 R132H mutation. In seven of these tumors, we found protein-disrupting point mutations in the remaining allele of CIC, four of which are novel. One of these tumors also had a deleterious mutation in FUBP1. Only by integrating RNA expression and array CGH data, were we able to discover an exon-spanning homozygous microdeletion within the remaining allele of CIC in an additional tumor with 1p/19q co-deletion. Therefore we propose that the mutation rate might be underestimated when looking at sequence variants alone. In conclusion, the high frequency and the spectrum of CIC mutations in our 1p/19q-codeleted tumor cohort support the hypothesis that CIC acts as a tumor suppressor in these tumors, whereas FUBP1 might play only a minor role. |
format |
article |
author |
Sophie Eisenreich Khalil Abou-El-Ardat Karol Szafranski Jaime A Campos Valenzuela Andreas Rump Janice M Nigro Rolf Bjerkvig Eva-Maria Gerlach Karl Hackmann Evelin Schröck Dietmar Krex Lars Kaderali Gabriele Schackert Matthias Platzer Barbara Klink |
author_facet |
Sophie Eisenreich Khalil Abou-El-Ardat Karol Szafranski Jaime A Campos Valenzuela Andreas Rump Janice M Nigro Rolf Bjerkvig Eva-Maria Gerlach Karl Hackmann Evelin Schröck Dietmar Krex Lars Kaderali Gabriele Schackert Matthias Platzer Barbara Klink |
author_sort |
Sophie Eisenreich |
title |
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
title_short |
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
title_full |
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
title_fullStr |
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
title_full_unstemmed |
Novel CIC point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
title_sort |
novel cic point mutations and an exon-spanning, homozygous deletion identified in oligodendroglial tumors by a comprehensive genomic approach including transcriptome sequencing. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/801c70ba21a348528b99e6c36c4f4533 |
work_keys_str_mv |
AT sophieeisenreich novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT khalilabouelardat novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT karolszafranski novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT jaimeacamposvalenzuela novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT andreasrump novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT janicemnigro novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT rolfbjerkvig novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT evamariagerlach novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT karlhackmann novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT evelinschrock novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT dietmarkrex novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT larskaderali novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT gabrieleschackert novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT matthiasplatzer novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing AT barbaraklink novelcicpointmutationsandanexonspanninghomozygousdeletionidentifiedinoligodendroglialtumorsbyacomprehensivegenomicapproachincludingtranscriptomesequencing |
_version_ |
1718421212451831808 |